BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16436277)

  • 1. Toll-like receptors--novel targets in allergic airway disease (probiotics, friends and relatives).
    Feleszko W; Jaworska J; Hamelmann E
    Eur J Pharmacol; 2006 Mar; 533(1-3):308-18. PubMed ID: 16436277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
    Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
    Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of innate immunity in the pathogenesis of asthma: evidence for the involvement of Toll-like receptor signaling.
    Schröder NW; Arditi M
    J Endotoxin Res; 2007; 13(5):305-12. PubMed ID: 17986489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders.
    Goldman M
    Clin Exp Immunol; 2007 Feb; 147(2):208-16. PubMed ID: 17223960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of CpG oligonucleotides in treatment of asthma and allergic disease.
    Fonseca DE; Kline JN
    Adv Drug Deliv Rev; 2009 Mar; 61(3):256-62. PubMed ID: 19167442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scientific rationale for the Finnish Allergy Programme 2008-2018: emphasis on prevention and endorsing tolerance.
    von Hertzen LC; Savolainen J; Hannuksela M; Klaukka T; Lauerma A; Mäkelä MJ; Pekkanen J; Pietinalho A; Vaarala O; Valovirta E; Vartiainen E; Haahtela T
    Allergy; 2009 May; 64(5):678-701. PubMed ID: 19383025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides.
    Wilson HL; Dar A; Napper SK; Marianela Lopez A; Babiuk LA; Mutwiri GK
    Int Rev Immunol; 2006; 25(3-4):183-213. PubMed ID: 16818371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of innate immunity in asthma: leads and lessons from mouse models.
    Schröder NW; Maurer M
    Allergy; 2007 Jun; 62(6):579-90. PubMed ID: 17508961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors: new therapeutic targets for the treatment of atherosclerosis, acute coronary syndromes, and myocardial failure.
    Erickson B; Sperber K; Frishman WH
    Cardiol Rev; 2008; 16(6):273-9. PubMed ID: 18923230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunoglobulin E-Toll-like receptor network.
    Novak N; Bieber T; Peng WM
    Int Arch Allergy Immunol; 2010; 151(1):1-7. PubMed ID: 19672091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells and toll-like receptors in allergy and asthma.
    Duez C; Gosset P; Tonnel AB
    Eur J Dermatol; 2006; 16(1):12-6. PubMed ID: 16436336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors.
    El Andaloussi A; Sonabend AM; Han Y; Lesniak MS
    Glia; 2006 Nov; 54(6):526-35. PubMed ID: 16906541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
    Krieg AM; Vollmer J
    Immunol Rev; 2007 Dec; 220():251-69. PubMed ID: 17979852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of airway epithelial cells in development of asthma and allergic rhinitis.
    Wang Y; Bai C; Li K; Adler KB; Wang X
    Respir Med; 2008 Jul; 102(7):949-55. PubMed ID: 18339528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles for accessory molecules in microbial recognition by Toll-like receptors.
    Miyake K
    J Endotoxin Res; 2006; 12(4):195-204. PubMed ID: 16953972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulators for allergic respiratory disorders.
    Casale TB; Stokes JR
    J Allergy Clin Immunol; 2008 Feb; 121(2):288-96; quiz 297-8. PubMed ID: 18269921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG motifs: the active ingredient in bacterial extracts?
    Krieg AM
    Nat Med; 2003 Jul; 9(7):831-5. PubMed ID: 12835699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptors on regulatory T cells: expanding immune regulation.
    Sutmuller RP; Morgan ME; Netea MG; Grauer O; Adema GJ
    Trends Immunol; 2006 Aug; 27(8):387-93. PubMed ID: 16814607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunostimulatory sequences in immunotherapy.
    Blanks DA
    Curr Opin Otolaryngol Head Neck Surg; 2007 Aug; 15(4):281-5. PubMed ID: 17620904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.